Deciphex news and updates

Diagnexia, Deciphex's digital pathology reporting service, connected to the Sectra Image Exchange Portal. Hospitals already on the portal can now send histopathology cases over their existing connection; Diagnexia checks the images, assigns each case to an available subspecialist and returns the report.

Our read

Sectra says portal sites get access with no new integration, supplier onboarding or infrastructure, which removes the usual barrier to outsourcing pathology reporting. For NHS trusts short of pathologists, that makes overflow reporting an option to switch on rather than a procurement project.

Deciphex launched CipherX, a pathology AI engine that pairs foundation models with a semantic layer translating their representations into named, pathologist validated tissue signatures. Deciphex states CipherX is in production in its Diagnexia clinical diagnostic service and its Patholytix research business, and reports negative predictive values of 99.85 percent for adenocarcinoma and 98.76 percent for melanoma in production, with every Diagnexia case signed out by a pathologist.

Our read

Labs using Diagnexia get CipherX inside the service rather than as a separate purchase. The predictive values are vendor reported, so ask for the case mix and prevalence behind them and which signatures are used in clinical sign out today rather than research only.